• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
topic report
National Breast Cancer Awareness Month pink ribbon
Favicon Fierce Biotech

After Enhertu: The slow hunt for next-gen HER2 breast cancer drugs

From dual-payload ADCs to bispecifics and radioligands, drugmakers are hunting for answers either after Enhertu progression or to replace it.
Angus Liu Oct 28, 2026 9:00am
Lilly

Lilly lifts guidance on back of another lucrative GLP-1 quarter

Oct 29, 2026 3:31pm
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Lenz plans for major layoffs and a CEO switch in Q4

Oct 29, 2026 3:15pm
Mark-Paul Gosselaar for AstraZeneca campaign

AZ enlists former teen TV star for biomarker testing push

Oct 29, 2026 2:41pm
comprehensive womens healthcare

Women 'still waiting' to trust healthcare institutions: report

Oct 29, 2026 2:30pm
Cute snail slowly climbing piles of coins

BMS' Cobenfy underwhelms expectations in Q3 report

Oct 29, 2026 11:35am
More News

For Merck, 2027 is ‘another year of investment’

Oct 29, 2026 11:23am

Novartis refreshes myelofibrosis bid as Geron flops in ph. 3

Oct 29, 2026 8:15am

Kennedy eases up enforcement on compounding of 6 peptides

Oct 29, 2026 8:12am

Apellis buyout fuels Biogen's best quarter since 2020

Oct 28, 2026 11:54am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings